dihydroginsenoside Rb1

intravenous infusion of dihydroginsenoside Rb1 prevents compressive spinal cord injury and ischemic brain damage through upregulation of VEGF and Bcl-XL; structure in first source

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Cao, Fang: 1 article (06/2007)
2.	Hata, Ryuji: 1 article (06/2007)
3.	Kuramoto, Makoto: 1 article (06/2007)
4.	Ma, Yong-Jie: 1 article (06/2007)
5.	Mitsuda, Noriaki: 1 article (06/2007)
6.	Sakanaka, Masahiro: 1 article (06/2007)
7.	Samukawa, Keiichi: 1 article (06/2007)
8.	Tanaka, Junya: 1 article (06/2007)
9.	Uno, Hidemitsu: 1 article (06/2007)
10.	Wen, Tong-Chun: 1 article (06/2007)

Related Diseases

1.

Spinal Cord Injuries (Spinal Cord Injury) 06/01/2007 - "In the present study, we produced dihydroginsenoside Rb1 (dgRb1), a stable chemical derivative of gRb1, and showed that intravenous infusion of dgRb1 improved spinal cord injury (SCI) as well as ischemic brain damage. " 06/01/2007 - "Intravenous infusion of dihydroginsenoside Rb1 prevents compressive spinal cord injury and ischemic brain damage through upregulation of VEGF and Bcl-XL."

Related Drugs and Biologics

1.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

Related Therapies and Procedures

1.	Intravenous Infusions